ArticleTobacco control2025
Self-reported exposure and reactions to cigarette corrective statements at the point-of-sale among US adults who smoke and youth.
Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionFollowing a historic 2006 US Federal Court ruling, major cigarette manufacturers were mandated to display corrective statements about smoking harms at the point-of-sale (POS) in about 200 000 tobacco retailers nationwide from October 2023 to June 2025. This study assessed sign exposure and reactions among US adults who smoke (AWS) cigarettes and youth.
methodsAn online survey was conducted in late 2024 with nationally representative samples of (≥21 years) AWS (n=1575) and youth aged 15-20 (n=1039). Respondents viewed image examples and reported sign exposure over the past 12 months. Measures included exposure frequency, sign reactions and sociodemographic and behavioural correlates. Weighted prevalence estimates and multivariable logistic regression were used.
resultsSelf-reported exposure was 26.2% among AWS and 18.4% among youth. Exposure was higher among more frequent visitors to chain convenience stores and gas stations, younger adults, AWS interested in quitting and youth who had tried cigarettes. Most exposed participants saw the signs multiple times and reported signage trust (80.2% AWS; 88.7% youth), support (85.3% AWS; 88.7% youth) and thoughts about smoking risks (71.4% AWS; 81.9% youth). Sign exposure was considerably lower than for tobacco ads at POS (84.0% AWS; 74.3% youth).
conclusionsAbout 18% of youth and 26% of smoking adults reported corrective statement exposure at POS. While exposure was positively associated with store visitation frequency, exposure was lower than for other tobacco POS messaging, suggesting that visual competition and limited retailer coverage may have constrained reach. Findings can inform future health messaging strategies in retail environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.